Advertisement
Research Article| Volume 32, ISSUE 4, P369-374, August 15, 1992

Download started.

Ok

Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression

DOI:https://doi.org/10.1016/0006-3223(92)90041-W
Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression
Previous ArticleAsterixis induced by carbamazepine therapy
Next ArticleSeason-of-birth effect reveals the existence of etiologically different groups of schizophrenia
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Baldessarini R.J.
        • Teicher M.H.
        • Cassidy J.W.
        • Stein M.H.
        Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drugs.
        J Clin Psychopharmacol. 1988; 8: 381-382
        • Ballenger J.C.
        The clinical use of carbamazepine in affective disorders.
        J Clin Psychiatry. 1988; 49 (Suppl): 13-19
        • Dalby M.A.
        Anti-epileptic and psychotropic effect of Carbamazepine in the treatment of psychomotor epilepsy.
        Epilepsia. 1971; 12: 325-334
        • De Montigny C.
        • Grunberg F.
        • Mayer A.
        • Deschenes J.P.
        Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders.
        Br J Psychiatry. 1981; 138: 252-256
        • De Montigny C.
        • Cournoyer G.
        • Morissette R.
        • Langlois R.
        • Caillé G.
        Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression.
        Arch Gen Psychiatry. 1983; 40: 1327-1334
        • Elphick M.
        Clinical issues in the use of carbamazepine in psychiatry: A review.
        Psychol Med. 1989; 19: 591-604
        • Elphick M.
        • Yang J.D.
        • Cowen P.J.
        Effects of carbamazepine on dopamine- and serotonin-mediated neuroendocrine responses.
        Arch Gen Psychiatry. 1990; 47: 135-140
        • Folstein M.
        • Folstein S.
        • McHugh T.R.
        Mini mental state examination.
        J Psychiatr Res. 1975; 12: 189-198
        • Fredholm B.B.
        • Dunwiddie T.V.
        How does adenosine inhibit transmitter release?.
        TIPS. 1988; 9: 130-134
        • Kobayashi A.
        • Kishimoto A.
        • Inagaki T.
        Treatment of periodic depression with carbamazepine.
        Acta Psychiatr Scand. 1988; 77: 364-367
        • Marangos P.J.
        • Post R.M.
        • Patel J.
        • Zander K.
        • Parma A.
        • Weiss S.
        Specific and potent interactions of carbamazepine with brain adenosine receptors.
        Eur J Pharmacol. 1983; 93: 175-182
        • Marangos P.J.
        • Patel J.
        • Smith K.D.
        • Post R.M.
        Epilepsia. 1987; 28: 387-394
        • Meltzer H.Y.
        Psychopharmacology: A Third Generation of Progress.
        Raven Press, New York1987
        • Nierenberg A.A.
        • Amsterdam J.D.
        Treatment-resistant depression: Definition and treatment approaches.
        J Clin Psychiatry. 1990; 51: 39-47
        • Post R.M.
        • Uhde T.W.
        • Roy-Byrne P.P.
        • Joffe R.T.
        Antidepressant effects of carbamazepine.
        Am J Psychiatry. 1986; 143: 29-34
        • Prasad A.J.
        Efficacy of carbamazepine as an antidepressant in chronic resistant depressives.
        J Indian Med Assoc. 1985; 83: 235-237
        • Pratt J.A.
        • Jenner P.
        • Reynolds E.H.
        • Shorvon S.D.
        Anticonvulsant drugs produce different effects on plasma tryptophan concentrations in epileptic patients.
        in: Schlossberger H.G. Kochen W. Linzen B. Steinhart H. Progress in Tryptophan and Serotonin Research. Walter de Gruyter, Berlin1984: 479-482
        • Pratt J.A.
        • Jenner P.
        • Marsden C.D.
        Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain.
        Neuropharmacology. 1985; 24: 59-68
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research diagnostic criteria: Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Takezaki H.
        • Hanaoka M.
        The use of carbamazepine in the control of manic-depressive psychosis and other manic, depressive states.
        Seishin Igaku. 1971; 13: 173-183

      Article info

      Publication history

      Received in revised form: March 3, 1992
      Received: May 18, 1991

      Identification

      DOI: https://doi.org/10.1016/0006-3223(92)90041-W

      Copyright

      © 1992 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX